Stream every public session from the 27th annual Global Conference right here on our website.

Watch Here
results for:

Content Type

Centers and Programs

Topics

Tags

Refine by Date

255
FasterCures Quarterly Update—April 2024 article
FasterCures Quarterly Update—April 2024
In This Newsletter New FasterCures Team Member Policy Updates Events and Convenings Recap FasterCur
es in the Community
Apr 11, 2024
The Milken Institute 2024 Global Opportunity Index Rankings Reflect Optimism Among Investors, While Financial Conditions Remain Tight Amid Warnings of Interest Rate Hikes and a Global Slowdown article
The Milken Institute 2024 Global Opportunity Index Rankings Reflect Optimism Among Investors, While Financial Conditions Remain Tight Amid Warnings of Interest Rate Hikes and a Global Slowdown
WASHINGTON, DC (March 5, 2024) — Optimism and opportunity, balanced against a world in flu
x, are influencing global investment decisions, according to a new report by the nonpartisan Milken Institute.
Mar 5, 2024
Tech Regulation Digest: Regulating Direct-to-Consumer Drug Marketing in the US: FDA and FTC Adapt to Changing Tech Landscape article
Tech Regulation Digest: Regulating Direct-to-Consumer Drug Marketing in the US: FDA and FTC Adapt to Changing Tech Landscape
Overview With the growing frontier of patient influencers using social media platforms to promote p
rescription drugs, increased attention is being paid to the impacts of social media advertising.
Feb 12, 2024
Request for Information on Improving Americans’ Access to Gene Therapies article
Request for Information on Improving Americans’ Access to Gene Therapies
Submitted electronically The Honorable Bill Cassidy, M.D. Ranking Member Committee on Health, Educa
tion, Labor & Pensions United States Senate Washington, DC 20510 Dear Ranking Member Cassidy,
Jan 22, 2024
Statement on the Zero-Draft Resolution of the “Scope, modalities, format and organization of the High Level Meeting on Antimicrobial Resistance convened by the President of the General Assembly” article
Statement on the Zero-Draft Resolution of the “Scope, modalities, format and organization of the High Level Meeting on Antimicrobial Resistance convened by the President of the General Assembly”
Submitted electronically 
Jan 18, 2024
FasterCures Quarterly Update—January 2024 article
FasterCures Quarterly Update—January 2024
In This Newsletter New FasterCures Team Members Recent FasterCures Publications Events and Convenin
gs Recap
Jan 30, 2024
TRAIN Newsletter — January 2024 article
TRAIN Newsletter — January 2024
In This Newsletter News From FasterCures TRAIN Organization Updates News You Can Use
Jan 18, 2024
Tech Regulation Digest: Biden Administration Moves on AI Regulation article
Tech Regulation Digest: Biden Administration Moves on AI Regulation
Overview On October 30, 2023, President Joe Biden signed an
Dec 20, 2023
FasterCures Quarterly Update—October 2023 article
FasterCures Quarterly Update—October 2023
In This Newsletter New Report: The Impact of Insight Convenings Recap Policy Updates: Pandemic and
All-Hazards Preparedness Act
Oct 26, 2023
Tech Regulation Digest: FTC Targets Amazon in Lawsuit amid Major Changes in Global Antitrust Laws article
Tech Regulation Digest: FTC Targets Amazon in Lawsuit amid Major Changes in Global Antitrust Laws
Overview On September 26, 2023, the Federal Trade Commission (FTC), along with 17 states, filed an
antitrust lawsuit against A
Oct 16, 2023
Food and Drug Administration (FDA) - Patient Perspectives on Gene Therapy Products article
Food and Drug Administration (FDA) - Patient Perspectives on Gene Therapy Products
Submitted electronically Division of Dockets Management (HFA-305) Food and Drug Administration Dock
et No: FDA-2022-N-2394 5630 Fishers Lane Room 1061 Rockville, MD 20852
Dec 15, 2022
Tech Regulation Digest: Big Tech, HIPAA, and the GDPR: Balancing Patient Privacy and Data Sharing in Health Tech article
Tech Regulation Digest: Big Tech, HIPAA, and the GDPR: Balancing Patient Privacy and Data Sharing in Health Tech
Overview As Big Tech companies face continued scrutiny over their handling of personal health infor
mation, the limitations of US health privacy regulation in a digital age are becoming more evident.
Jan 19, 2023